Medpace Holdings Net Income
| MEDP Stock | USD 444.13 15.95 3.73% |
As of the 18th of February 2026, Medpace Holdings secures the Risk Adjusted Performance of (0.14), mean deviation of 1.6, and Standard Deviation of 2.67. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medpace Holdings, as well as the relationship between them.
Medpace Holdings Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 4.6496 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 451.1 M | 473.7 M | |
| Net Income From Continuing Ops | 451.1 M | 473.7 M | |
| Net Income Applicable To Common Shares | 282.2 M | 296.3 M | |
| Net Income Per Share | 15.64 | 16.42 | |
| Net Income Per E B T | 0.83 | 0.65 |
Medpace | Net Income | Build AI portfolio with Medpace Stock |
Evaluating Medpace Holdings's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Medpace Holdings's fundamental strength.
Latest Medpace Holdings' Net Income Growth Pattern
Below is the plot of the Net Income of Medpace Holdings over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Medpace Holdings financial statement analysis. It represents the amount of money remaining after all of Medpace Holdings operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Medpace Holdings' Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medpace Holdings' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 451.12 M | 10 Years Trend |
|
Net Income |
| Timeline |
Medpace Net Income Regression Statistics
| Arithmetic Mean | 146,229,656 | |
| Geometric Mean | 71,258,178 | |
| Coefficient Of Variation | 113.69 | |
| Mean Deviation | 136,686,613 | |
| Median | 73,185,000 | |
| Standard Deviation | 166,251,577 | |
| Sample Variance | 27639.6T | |
| Range | 489.3M | |
| R-Value | 0.90 | |
| Mean Square Error | 5629T | |
| R-Squared | 0.81 | |
| Slope | 29,613,427 | |
| Total Sum of Squares | 442233.4T |
Medpace Net Income History
Other Fundumenentals of Medpace Holdings
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Medpace Holdings Net Income component correlations
Medpace Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Medpace Holdings is extremely important. It helps to project a fair market value of Medpace Stock properly, considering its historical fundamentals such as Net Income. Since Medpace Holdings' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Medpace Holdings' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Medpace Holdings' interrelated accounts and indicators.
Click cells to compare fundamentals
Can Life Sciences Tools & Services industry sustain growth momentum? Does Medpace have expansion opportunities? Factors like these will boost the valuation of Medpace Holdings. Expected growth trajectory for Medpace significantly influences the price investors are willing to assign. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Medpace Holdings demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth 0.269 | Earnings Share 15.28 | Revenue Per Share | Quarterly Revenue Growth 0.32 | Return On Assets |
Understanding Medpace Holdings requires distinguishing between market price and book value, where the latter reflects Medpace's accounting equity. The concept of intrinsic value - what Medpace Holdings' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push Medpace Holdings' price substantially above or below its fundamental value.
Understanding that Medpace Holdings' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Medpace Holdings represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Medpace Holdings' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Medpace Holdings 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medpace Holdings' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medpace Holdings.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in Medpace Holdings on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding Medpace Holdings or generate 0.0% return on investment in Medpace Holdings over 90 days. Medpace Holdings is related to or competes with Illumina, ICON PLC, Hologic, Waters, Centene Corp, Smith Nephew, and Quest Diagnostics. Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, E... More
Medpace Holdings Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medpace Holdings' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medpace Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.20) | |||
| Maximum Drawdown | 20.4 | |||
| Value At Risk | (3.61) | |||
| Potential Upside | 3.02 |
Medpace Holdings Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medpace Holdings' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medpace Holdings' standard deviation. In reality, there are many statistical measures that can use Medpace Holdings historical prices to predict the future Medpace Holdings' volatility.| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (0.52) | |||
| Total Risk Alpha | (0.63) | |||
| Treynor Ratio | (0.63) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Medpace Holdings' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Medpace Holdings February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.14) | |||
| Market Risk Adjusted Performance | (0.62) | |||
| Mean Deviation | 1.6 | |||
| Coefficient Of Variation | (555.70) | |||
| Standard Deviation | 2.67 | |||
| Variance | 7.1 | |||
| Information Ratio | (0.20) | |||
| Jensen Alpha | (0.52) | |||
| Total Risk Alpha | (0.63) | |||
| Treynor Ratio | (0.63) | |||
| Maximum Drawdown | 20.4 | |||
| Value At Risk | (3.61) | |||
| Potential Upside | 3.02 | |||
| Skewness | (2.97) | |||
| Kurtosis | 16.72 |
Medpace Holdings Backtested Returns
Medpace Holdings has Sharpe Ratio of -0.17, which conveys that the firm had a -0.17 % return per unit of risk over the last 3 months. Medpace Holdings exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Medpace Holdings' Risk Adjusted Performance of (0.14), mean deviation of 1.6, and Standard Deviation of 2.67 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.78, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Medpace Holdings' returns are expected to increase less than the market. However, during the bear market, the loss of holding Medpace Holdings is expected to be smaller as well. At this point, Medpace Holdings has a negative expected return of -0.49%. Please make sure to verify Medpace Holdings' treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Medpace Holdings performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.05 |
Virtually no predictability
Medpace Holdings has virtually no predictability. Overlapping area represents the amount of predictability between Medpace Holdings time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medpace Holdings price movement. The serial correlation of 0.05 indicates that only as little as 5.0% of current Medpace Holdings price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.05 | |
| Spearman Rank Test | 0.07 | |
| Residual Average | 0.0 | |
| Price Variance | 4189.31 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Medpace Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Medpace Holdings reported net income of 451.12 M. This is 32.18% higher than that of the Life Sciences Tools & Services sector and 160.6% higher than that of the Health Care industry. The net income for all United States stocks is 20.99% higher than that of the company.
Medpace Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medpace Holdings' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medpace Holdings could also be used in its relative valuation, which is a method of valuing Medpace Holdings by comparing valuation metrics of similar companies.Medpace Holdings is currently under evaluation in net income category among its peers.
Medpace Holdings ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Medpace Holdings' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Medpace Holdings' managers, analysts, and investors.Environmental | Governance | Social |
Medpace Holdings Institutional Holders
Institutional Holdings refers to the ownership stake in Medpace Holdings that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Medpace Holdings' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Medpace Holdings' value.| Shares | Td Asset Management Inc | 2025-06-30 | 457.6 K | Amvescap Plc. | 2025-06-30 | 451.9 K | Td Global Investment Solutions – Td Epoch | 2025-06-30 | 445.2 K | Riverbridge Partners Llc | 2025-06-30 | 434 K | Dimensional Fund Advisors, Inc. | 2025-06-30 | 414.1 K | Millennium Management Llc | 2025-06-30 | 344.9 K | D. E. Shaw & Co Lp | 2025-06-30 | 343.6 K | Northern Trust Corp | 2025-06-30 | 336.7 K | Jane Street Group Llc | 2025-06-30 | 311.8 K | Blackrock Inc | 2025-06-30 | 2.5 M | Vanguard Group Inc | 2025-06-30 | 2.4 M |
Medpace Fundamentals
| Return On Equity | 0.7 | ||||
| Return On Asset | 0.16 | ||||
| Profit Margin | 0.18 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 11.76 B | ||||
| Shares Outstanding | 28.38 M | ||||
| Shares Owned By Insiders | 19.40 % | ||||
| Shares Owned By Institutions | 85.40 % | ||||
| Number Of Shares Shorted | 1.34 M | ||||
| Price To Earning | 49.07 X | ||||
| Price To Book | 26.46 X | ||||
| Price To Sales | 4.80 X | ||||
| Revenue | 2.53 B | ||||
| Gross Profit | 1.8 B | ||||
| EBITDA | 570.5 M | ||||
| Net Income | 451.12 M | ||||
| Cash And Equivalents | 31.01 M | ||||
| Cash Per Share | 1.00 X | ||||
| Total Debt | 250.5 M | ||||
| Debt To Equity | 0.85 % | ||||
| Current Ratio | 0.41 X | ||||
| Book Value Per Share | 16.18 X | ||||
| Cash Flow From Operations | 713.22 M | ||||
| Short Ratio | 6.33 X | ||||
| Earnings Per Share | 15.28 X | ||||
| Price To Earnings To Growth | 2.14 X | ||||
| Target Price | 490.5 | ||||
| Number Of Employees | 6.2 K | ||||
| Beta | 1.4 | ||||
| Market Capitalization | 12.15 B | ||||
| Total Asset | 1.98 B | ||||
| Retained Earnings | (459.98 M) | ||||
| Working Capital | (354.12 M) | ||||
| Current Asset | 94.72 M | ||||
| Current Liabilities | 134.02 M | ||||
| Net Asset | 1.98 B |
About Medpace Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medpace Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medpace Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medpace Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Medpace Holdings
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medpace Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medpace Holdings will appreciate offsetting losses from the drop in the long position's value.Moving together with Medpace Stock
| 0.67 | A | Agilent Technologies Earnings Call Today | PairCorr |
Moving against Medpace Stock
The ability to find closely correlated positions to Medpace Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medpace Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medpace Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medpace Holdings to buy it.
The correlation of Medpace Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medpace Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medpace Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medpace Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Medpace Stock Analysis
When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.